Tipifarnib-mediated suppression of T-bet-dependent signaling pathways.
Bai F; Villagra AV; Zou J; Painter JS; Connolly K; Blaskovich MA; Sokol L; Sebti S; Djeu JY; Loughran TP; Wei S; Sotomayor E; Epling-Burnette P; Cancer Immunology, Immunotherapy: CII, 2012, vol. 61, issue 4, p 523, ISSN 14320851. ISBN 14320851.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef